AAIC 2025 Abstract·25 DecTrajectories of CSF and plasma MTBR‐tau 243 and phosphorylated‐tau species across the Alzheimer's disease continuumStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecBiological staging of Alzheimer's disease with the novel plasma eMTBR‐tau243 and %p‐tau217Study in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecAssociations between tau PET and CSF MTBR243 do not vary by sexStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecReference proteins to improve performance of core 1 and core 2 Alzheimer's disease CSF and plasma biomarkersStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecBiological staging of Alzheimer’s disease with the novel plasma eMTBR‐tau243 and % p ‐tau217Study in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecTarget Engagement of Lecanemab on CSF Aβ Protofibril Toxic Species in Clarity ADTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecMTBR‐tau243 biomarker specifically identifies mixed 3R/4R tauopathiesStudy in peopleBiomarkersPaper